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Over the past decade, the Hippo tumor suppressor pathway has emerged as a central regulator of growth in
epithelial tissues. Research in Drosophila and in mammals has shown that this kinase signaling cascade
regulates the activity of the transcriptional coactivator and oncoprotein Yorkie/Yap. In this review,we discuss
recent findings that emphasize the cell cortex—specifically the actin cytoskeleton, intercellular junctions, and
protein complexes that determine cell polarity—as a key site for Hippo pathway regulation. We also highlight
where additional research is needed to integrate known functional interactions between Hippo pathway
components.Introduction
The Hippo (Hpo) tumor suppressor pathway is a conserved
signaling pathway that regulates levels of cell proliferation and
apoptosis in growing epithelial tissues. First identified in
Drosophila, the Hpo pathway has since been implicated in
mammalian organ size control and several types of human
cancer (Pan, 2010; Chan et al., 2011a). The founding member
of the pathway, Warts (Wts), was discovered in genetic mosaic
screens designed to identify genes involved in cell growth and
proliferation (Justice et al., 1995; Xu et al., 1995). Drosophila
wts encodes a Ser/Thr kinase that bears significant homology
to Cbk1 and the cell-cycle regulators Dbf20 and Dbf2 in budding
yeast. In mosaic animals, wts mutant cells overproliferate com-
pared to their wild-type neighbors and form cuticular outgrowths
from highly folded epithelial tissue. Subsequent genetic screens
have revealed other genes, including salvador (sav), hippo (hpo),
and mob as tumor suppressor (mats), that give strikingly similar
phenotypes when clonally deleted in imaginal discs (Kango-
Singh et al., 2002; Tapon et al., 2002; Harvey et al., 2003; Panta-
lacci et al., 2003; Udan et al., 2003; Wu et al., 2003; Lai et al.,
2005). Studies in Drosophila and in mammals have shown that
Hpo, Sav, and Wts (and their mammalian orthologs MST1/2,
WW45, and Lats1/2, respectively) form a protein complex that
negatively regulates the oncoprotein and transcriptional co-
activator Yorkie (Yki) or its mammalian orthologs Yap and Taz
(Figure 1; Tapon et al., 2002; Harvey et al., 2003; Pantalacci
et al., 2003; Udan et al., 2003; Wu et al., 2003; Huang et al.,
2005; Lai et al., 2005; Callus et al., 2006). Biochemical experi-
ments have shown that Hpo/MST can phosphorylate and acti-
vate Wts/Lats, which in turn phosphorylates and inactivates
Yki/Yap (Wu et al., 2003; Chan et al., 2005; Huang et al., 2005;
Dong et al., 2007; Wei et al., 2007; Zhao et al., 2007; Oh and Ir-
vine, 2008). The phosphorylation of Yki/Yap at several key serine
residues promotes cytoplasmic retention by 14-3-3 and inhibits
the transcription of genes that promote tissue growth (Huang
et al., 2005; Zhao et al., 2007; Oh and Irvine, 2008; Oh and Irvine,2009). Sav/WW45 and Mats are thought to function primarily
as scaffolding proteins to promote Hpo/MST and Wts/Lats acti-
vation, respectively. In the absence of pathway function, Yki/Yap
accumulates in the nucleus, where it binds to Scalloped/TEAD
to form an active transcription factor complex that drives expres-
sion of growth-promoting genes (Wu et al., 2008; Zhang et al.,
2008; Zhao et al., 2008).
Although the intracellular signaling events downstream of
Hpo/MST that lead to Yki/Yap inactivation are largely defined,
it remains less clear how the pathway is regulated upstream of
Hpo/MST. Moreover, it is unknown to what extent extracellular
cues play a role in activating the pathway. Over the past year
or two, significant progress has been made in identifying
new Hpo pathway components and establishing links between
Hpo signaling and the actin cytoskeleton, cell junctions, and
cell polarity. In this review, we discuss recent advances in our
understanding of upstream regulation of the Hpo pathway and
how basic cellular processes such as actin polymerization and
cell junctions influence Hpo signaling.
Bridging Cell Junctions and Hpo Signaling
Intercellular junctions, once primarily thought of as structural
components, have been shown to play critical roles in cell sig-
naling events—perhaps the best example being the dual func-
tions of b-catenin as an adherens junction (AJ) protein and
transcriptional coactivator for Wnt signaling (Jeanes et al.,
2008). By functioning at the site of cell-cell contacts, junctional
proteins are ideally positioned to monitor the extracellular envi-
ronment and transmit growth inhibitory signals when cells reach
high cell density. A central tenant of thismodel is that intercellular
junctions trigger intracellular signaling events that inhibit further
cell division and growth. As a critical regulator of epithelial tissue
growth, the Hpo pathway is a good candidate for receiving
growth inhibitory signals from cell junctions in polarized epithelial
cells. Evidence that junctional complexes might signal through
the Hpo pathway to inhibit cell proliferation first came fromDevelopmental Cell 22, April 17, 2012 ª2012 Elsevier Inc. 695
Figure 1. Functionally Conserved Components of the Hippo Tumor
Suppressor Pathway
The FERM domain proteins Merlin and Expanded/FMD6 have been proposed
to function upstream of the core kinase signaling cassette together with the
WW domain protein Kibra. The sterile 20 kinase Tao-1 directly phosphorylates
Hippo and MST kinases in vitro and promotes pathway activation in vivo. The
scaffolding proteins Salvador/WW45 and Mats/Mob promote Hippo/MST and
Warts/Lats kinase activity, respectively. Hippo/MST phosphorylates Warts/
Lats, which in turn phosphorylates Yorkie/Yap to promote 14-3-3 binding.
14-3-3 sequesters Yorkie/Yap in the cytoplasm, preventing the transcription of
target genes that promote tissue growth. In addition, Fat signaling (not shown)
has been shown to regulate Warts stability and Yorkie activation in parallel to
Hippo.
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are inversely correlated with cell density (Zhao et al., 2007; Ota
and Sasaki, 2008). At low cell density Yap is enriched within
the nucleus and weakly phosphorylated, whereas at high cell
density Yap is predominantly cytoplasmic and strongly phos-
phorylated. The latter observation suggests that MST and Lats
kinase activity upstream of Yap are also regulated by cell density
(Zhao et al., 2007), though this has not been directly demon-
strated.
One potential mechanism by which intercellular junctions
might regulate Hpo signaling is through junctional proteins
sequestering pathway components, thereby preventing their
participation in signaling. This sort of mechanism has been pro-
posed for the AJ in sequestering b-catenin and thus preventing it
from participating inWnt-pathway signaling (Jeanes et al., 2008).696 Developmental Cell 22, April 17, 2012 ª2012 Elsevier Inc.The first evidence for this type of mechanism in the Hpo pathway
came from studies in Drosophila that demonstrate that Yki binds
directly to Expanded (Ex), a FERM domain protein (Figure 2;
Badouel et al., 2009), and forms a complex with Hpo and Wts
(Oh et al., 2009). These papers represented a fundamental shift
in the Drosophila Hpo signaling paradigm because the results
clearly demonstrated that Yki activity can be regulated indepen-
dently of its phosphorylation state, thus blurring the lines
between ‘‘upstream’’ and ‘‘downstream’’ Hpo pathway compo-
nents. Prior to this study, the prevailing model was that Ex and
Merlin function upstream of the core Hpo signaling cassette to
regulate pathway activation (Hamaratoglu et al., 2006). Interest-
ingly, like Merlin, Ex localizes closely to AJs in the fly epithelium
and has been implicated in regulating the endocytosis of
transmembrane proteins such as Notch, E-cadherin, Fat, and
EGFR (McCartney et al., 2000; Maitra et al., 2006). Studies in
Drosophila have shown that both the protocadherin Fat and
the apical polarity protein Crumbs (Crb) regulate Ex subcellular
localization, suggesting that Ex might be part of a larger junc-
tional complex that functions to inhibit Yki transcriptional activity
(Bennett and Harvey, 2006; Cho et al., 2006; Silva et al., 2006;
Willecke et al., 2006; Chen et al., 2010; Grzeschik et al., 2010;
Ling et al., 2010; Robinson et al., 2010). In support of this notion,
the adhesionmolecule Echinoid (Ed) and theWWdomain protein
Kibra were recently identified as Hpo pathway members that
interact with both Ex and Yki (Figure 2; Baumgartner et al.,
2010; Genevet et al., 2010; Yu et al., 2010, 2012). Interestingly,
loss of Ed in the wing epithelium results in the mislocalization
of Sav from the subapical cell membrane but does not have an
effect on the localization of Ex and Merlin.
Recently, several studies have built on these observations by
linking Yap to both AJ and tight junction (TJ) proteins and
revealing additional mechanisms of Yap inactivation (Figure 2).
Two groups recently showed that Yap interacts with the AJ
protein a-catenin in primary mouse keratinocytes (Schlegelmilch
et al., 2011; Silvis et al., 2011). Overexpression of activated Yap
in keratinocytes results in a skin carcinoma-like phenotype that is
accompanied by expansion of the basal stem cell population.
Loss of a-catenin or disruption of AJs with EGTA in confluent
keratinocytes results in increased nuclear Yap, suggesting
that the AJ is a key mediator of Yap subcellular localization.
Moreover, knockdown of a-catenin increases Yap transcrip-
tional activity in epithelial-derived cell lines. Surprisingly, loss
of MST1/2 had no effect on skin proliferation in vivo, suggesting
that Yap activity is primarily regulated by a-catenin in this context
(Schlegelmilch et al., 2011). Silvis et al. (2011) also found that the
Yap phosphorylation state remained constant in a-catenin/
cells when normalized to total Yap levels, as did Lats phosphor-
ylation. Taken together, these results suggest that Yap is regu-
lated independently of canonical Hpo signaling in the epidermis;
however, it is important to note that 14-3-3, which specifically
binds phosphorylated Yap, was also identified as an a-catenin
binding protein and found to be necessary for a-catenin and
Yap binding in vitro (Schlegelmilch et al., 2011). Thus, it seems
possible that other kinases take the place of MST and Lats in
regulating the interaction between Yap and a-catenin in the
epidermis.
Potentially a key player in mediating density-dependent
regulation of Yki/Yap function is Merlin, the product of the
Figure 2. Yorkie/Yap Activity Is Regulated by Apical Junctions and Polarity Proteins
In Drosophila, the FERM domain protein Expanded has been shown to physically interact with Yorkie at the cell membrane and prevent its translocation to the
nucleus. The adhesion molecule Echinoid coimmunoprecipitates with several Hippo pathway components in S2 cells, including Yorkie, and promotes pathway
activation. Fat and Crumbs are both large transmembrane proteins that localize to the subapical membrane and adherens junctions, respectively, and regulate
the subcellular localization of Expanded. In addition, Fat is believed to regulate the Hippo/Salvador/Warts (HSW) kinase cascade independently of Expanded. In
mammals, the adherens junction (AJ) protein a-catenin inhibits Yap activity by recruiting it to the cell membrane. In a similar fashion, the TJ protein AMOT and the
subapical Crumbs complex (Crb3, Pals1, and PatJ) were recently shown to sequester Yap/Taz to the TJ, thereby inhibiting its oncogenic activity. For clarity,
interactions with the HSW cascade have been omitted from the mammalian cell.
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of the FERM domain superfamily, a group of proteins that have
the ability to interact with the cytoplasmic tail of select trans-
membrane proteins, as well as other cortical cytoplasmic pro-
teins. As such, Merlin and other FERM domain proteins can
coordinate protein interactions and intercellular signaling while
functioning at the cytoplasmic face of the plasma membrane
(McClatchey and Fehon, 2009). In Drosophila, immunolocali-
zation studies place Merlin in the apical junctional zone, in
close proximity to both the AJ and the apical polarity proteins
(McCartney and Fehon, 1996). In mammalian cells, Merlin has
been shown to mediate contact inhibition that suppresses cell
division in cultured cells (Lallemand et al., 2003), and its phos-
phorylation state is dependent on cell density (Shaw et al.,
1998). In addition, a recent study has shown that Merlin physi-
cally interacts with a-catenin and Par3 in keratinocytes, suggest-
ing thatMerlin plays a role in linking cell polarity proteins to the AJ
complex (Gladden et al., 2010). In Drosophila, Merlin has been
shown to be an upstream regulator of Hpo pathway function
(Hamaratoglu et al., 2006). Similarly, a recent study in the liver
has found that mammalian Merlin functions antagonistically
to Yap in liver homeostasis (Zhang et al., 2010), though other
studies have suggested that Merlin functions independently
of Yap in both the skin and liver (Benhamouche et al., 2010;
Gladden et al., 2010). These studies raise a number of interesting
but as-yet-unanswered questions, including whether Merlin,
Yap, and a-catenin form a complex at the AJ to restrict cell prolif-
eration, how cell density regulates Merlin phosphorylation and
activity, and whether Merlin has growth regulatory functions
that are independent of its function in Hpo signaling. Regardless,Merlin seems an ideal candidate to mediate density-dependent
signals that regulate growth.
In addition to interacting with a-catenin, Merlin was recently
shown to bind angiomotin (AMOT) and localize to TJs (Figure 2;
Yi et al., 2011). In this study, Merlin was found to compete with
Rich1 for AMOT binding, thereby activating Rich1 and inhibiting
Ras-MAPK signaling. Several recent papers have also shown
that Yap and its close relative Taz can directly bind to AMOT
family proteins (Chan et al., 2011b; Wang et al., 2011; Zhao
et al., 2011). As with a-catenin, this interaction occurs indepen-
dently of canonical Hpo signaling because mutating critical Lats
phosphorylation residues does not prevent the association and
inhibition of Yap by AMOT proteins (Zhao et al., 2011). Moreover,
Yap requires its WW1 domain to bind AMOT, which is the same
domain used to interact with TEAD-family transcription factors,
suggesting that AMOT might restrict Yap transcriptional activity
by competing for these binding sites. AMOT was first identified
as a binding partner of angiostatin in yeast two-hybrid screens
but has since been shown to function in maintaining TJs through
association with an apical polarity complex consisting of PatJ,
Par3, and Rich1 (Troyanovsky et al., 2001; Wells et al., 2006).
Knockdown of AMOTL2 in MDCK cells results in an EMT-like
phenotype characterized by increased cell migration, decreased
E-cadherin, and loss of cell-cell junctions, indicating that AMOT
proteins are required to maintain epithelial identity (Wang et al.,
2011). In primary keratinocytes, however, knockdown of AMOT
family proteins does not cause any abnormalities, suggesting
that in this context Yap regulation by AMOT might not be phys-
iologically relevant (Silvis et al., 2011). Nonetheless, the finding
that Merlin and Yap both interact with AMOT is intriguing, givenDevelopmental Cell 22, April 17, 2012 ª2012 Elsevier Inc. 697
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Although there is no obvious AMOT homolog in Drosophila,
Merlin physically interacts with the adhesion protein Ed and
the WW domain proteins Sav and Kibra in Drosophila S2 cells
(Yu et al., 2010; Yue et al., 2012).
Taken together, these studies raise the intriguing possibility
that intercellular junctions negatively regulate tissue growth by
sequestering Yki/Yap to the cell cortex. However, it is important
to note that a key prediction of this model, that Yki/Yap should
localize to the junctional complex, has not been universally
observed. Whereas in some studies recruitment of Yki/Yap to
the junctional region has been clearly demonstrated (Zhang
et al., 2009; Zhao et al., 2011), in others Yki/Yap seems more
uniformly cytoplasmic in distribution (Silvis et al., 2011). Addi-
tional studies will be required to determine what role Merlin
and other junctionally localized proteins play in sequestering
Yki/Yap and other Hpo pathway components to junctional
protein complexes.
The Cytoskeleton and Hpo Pathway Activation
For some time now, it has been recognized that the actin
cytoskeleton is required for the morphological and cell-cycle
changes that accompany cell-cell adhesion and extracellular
matrix (ECM) binding (Mammoto and Ingber, 2009). Studies
surrounding the actin cytoskeleton and cell growth have focused
primarily on the Rho family of small GTPases because of their
involvement in promoting actin polymerization and cytoskeletal
tension. For instance, RhoA promotes stress fiber formation
and ERK-dependent cell-cycle progression in response to cell
tension (Assoian and Klein, 2008). The related small GTPase
Rac promotes cell-cycle progression in response to integrin
receptor binding at the ECM (Fournier et al., 2008). More
recently, the actin cytoskeleton has been shown to regulate
cell proliferation through the Hpo pathway in both flies and
mammals. In mammalian tissue culture, Yap activity and sub-
cellular localization is influenced by changes in cell morphology
and the actin cytoskeleton, although there is currently some
debate about whether core Hpo signaling components are
involved (Dupont et al., 2011; Wada et al., 2011; Zhao et al.,
2012). For example, Wada et al. (2011) and Zhao et al. (2012)
showed that disrupting the actin cytoskeleton regulates Yap
activity in a Lats-dependent fashion. In addition, Lats kinase
activity and its ability to phosphorylate Yap in vitro aremodulated
by pharmacological inhibition of microtubules (MTs) and F-actin
(Zhao et al., 2012). An earlier study came to a different con-
clusion because disrupting F-actin did not affect Yap phosphor-
ylation levels andmutating critical Lats phosphorylation residues
did not prevent Yap inactivation by mechanical stress (Dupont
et al., 2011). This discrepancy could be due to differences in
methodology, as well as the fact that different cell lines were
used. Interestingly, inhibition or overexpression of RhoA also
influenced Yap activation, suggesting that the Rho pathway
impinges on Hpo signaling (Zhao et al., 2012). This effect is likely
due to RhoA’s known ability to promote actin polymerization,
though it could also relate to increased cortical contractility.
In agreement with the above studies in mammalian cells,
recent work in Drosophila has revealed that several actin-
modulating proteins influenceHpo pathway activation. Knocking
down capping protein A or expressing a constitutively active698 Developmental Cell 22, April 17, 2012 ª2012 Elsevier Inc.form of the formin Diaphanous (Dia) results in increased
Yki activity and tissue overgrowth, suggesting that increased
F-actin accumulation promotes growth (Ferna´ndez et al., 2011;
Sansores-Garcia et al., 2011). However, increasing cortical
F-actin by other means, for example by expressing an activated
form of the actin-binding protein Moesin or mutating the cofilin
protein Twinstar, does not result in tissue overgrowth (Speck
et al., 2003; Neisch and R.G.F., unpublished data; Ferna´ndez
et al., 2011), indicating that the relationship between F-actin
and growth is complicated. In addition, Ferna´ndez et al. (2011)
found that loss of hpo, sav,wts, ex, ormats resulted in increased
levels of F-actin, suggesting that Hpo signaling negatively regu-
lates actin polymerization or stability. It remains to be resolved
how F-actin is regulated by Hpo signaling, and it is worth noting
that there are conflicting reports on whether Yki expression
promotes F-actin accumulation in vivo (Fang and Adler, 2010;
Ferna´ndez et al., 2011), leaving open the possibility that actin
accumulation is not downstream of Yki’s transcriptional role.
Interestingly, phospho-Moesin staining is also increased in
Hpo pathway mutants (Polesello and Tapon, 2007; Vanderzalm
and R.G.F., unpublished data), suggesting that Moesin might
be responsible for the observed F-actin accumulation.
It remains unclear how the actin cytoskeleton regulates Hpo
signaling to elicit growth responses. One possibility is that Zyxin,
which was recently identified as a negative regulator of Hpo
signaling, integrates information about mechanical tension
from the actin cytoskeleton with Hpo signaling (Rauskolb et al.,
2011). Zyxin has been proposed to function within the Fat
signaling branch of the Hpo pathway to regulate Wts protein
stability in conjunction with the atypical myosin Dachs. Zyxin
localizes to points of cell-cell contact in the wing epithelium
and to focal adhesions in mammalian fibroblasts (Beckerle,
1997; Hirata et al., 2008; Rauskolb et al., 2011), making it an ideal
candidate for transmitting signals about mechanical tension to
the Hpo pathway.
It will also be important to determine what contribution, if any,
MTsmake to Hpo pathway regulation. The recent demonstration
that Tao-1 acts as a Hpo pathway component and directly phos-
phorylates Hpo (Boggiano et al., 2011; Poon et al., 2011)
provides a possible mechanistic link between MTs, the actin
cytoskeleton, and Hpo signaling. Tao-1 is known to negatively
regulate MT stability in both mammals and Drosophila (Mitso-
poulos et al., 2003; Timm et al., 2003; Liu et al., 2010; King
et al., 2011). InDrosophila S2 cells, knocking down Tao-1 results
in MT protrusions that resemble the effects of disrupting cortical
actin, suggesting that Tao-1 might destabilize MTs at the cell
cortex in response to signals from the actin cytoskeleton (Liu
et al., 2010). In mammalian cells, Tao-1 functions through
Par-1 and Tau to regulate MT stability and physically interacts
with the actin-modulating proteins Tesk1 and Spred1 (King
and Heberlein, 2011). Thus, in addition to regulating MT stability,
Tao-1 appears to function at the interface between the actin and
MT cytoskeletons. An interesting, though still speculative, possi-
bility is that in addition to regulating MT stability, Tao-1 activity
itself might be regulated by interaction with the MT and/or actin
cytoskeletons. Indeed, a recent study suggests that Tao-1
activity is enhanced at the cell cortex (Liu et al., 2010). Although
more studies will be needed to fully elucidate the role of Tao-1 in
regulating cytoskeletal dynamics, it is tempting to propose that
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skeletons to regulate Hpo signaling.
Cell Polarity and the Hpo Pathway
Polarized epithelial cells consist of an apical and basolateral
membrane domain that is separated by cell-cell junctions
(St Johnston and Ahringer, 2010). The membrane domains and
the position of the junctions are defined by mutual antagonism
between apical and basolateral protein complexes. Studies in
Drosophila have revealed that many of the proteins that regulate
cell polarity also function to control growth in epithelial tissues
(Hariharan and Bilder, 2006). These include the apical polarity
protein Crumbs (Crb) and the basolateral polarity proteins Lethal
giant larvae (Lgl), Discs large (Dlg), and Scribble (Scrib). Loss of
lgl gives rise to the ‘‘giant larvae’’ phenotype for which the gene
was named more than 40 years ago (Schneiderman and Gateff,
1967). In addition, it has long been recognized that loss of
cell polarity is one of the changes that accompanies EMT in
advanced-stage cancers (Wodarz and Na¨thke, 2007). An inter-
esting but perplexing question is how the loss of cell polarity
contributes to tumorigenesis in epithelial tissues. One possibility,
supported by evidence that E-cadherin is also downregulated in
many human cancers, is that loss of cell polarity results in defec-
tive cell adhesion and contact inhibition. Indeed, loss of apical
and basolateral polarity proteins in Drosophila has been shown
to disrupt adherens junctions during embryogenesis (Tepass
et al., 2001; Harris and Peifer, 2004). Another possibility, as
alluded to earlier, is that cell polarity proteins directly regulate
the signaling pathways that control tissue growth. Shedding
some light on this, recent studies have linked both apical and
basolateral polarity proteins to the Hpo pathway (Chen et al.,
2010; Grzeschik et al., 2010; Ling et al., 2010; Robinson et al.,
2010; Varelas et al., 2010).
The apical polarity protein Crb was recently identified as
a component of the Hpo pathway in Drosophila and found to
regulate the subcellular localization of Ex (Chen et al., 2010;
Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010).
Interestingly, both loss and overexpression of Crb in the wing
epithelium causes overgrowth phenotypes. Crb contains two
functionally important subdomains within its cytoplasmic tail,
a PDZ binding motif (PBM), which physically interacts with other
apical polarity proteins, and a FERM binding motif (FBM), which
physically interacts with Ex and another FERM domain protein
called Yurt (Ling et al., 2010; St Johnston and Ahringer, 2010;
Robinson et al., 2010). To determine which of these domains
mediates the growth regulatory activity of Crb, Robinson et al.
(2010) performed in vivo experiments using transgenic animals
carrying different pieces of the Crb intracellular domain. They
found that overexpression of the FBM was sufficient to drive
overgrowth in the absence of the PBM and that overexpression
of the PBM did not cause overproliferation, but instead altered
cell polarity. In addition, another study found that Ex protein
was mislocalized in a crb allele lacking the FBM (crbDFBM) but
that Ex was normally localized in an allele lacking the PBM
(crbDPBM; Ling et al., 2010). Adult crbDFBM wings were also signif-
icantly overgrown when compared to wild-type controls, sug-
gesting that Crb regulates Hpo signaling through its FBM. Thus,
recent work onCrbwould argue that cell polarity and cell prolifer-
ation are regulated through distinct protein-protein interactions.Themammalian Crb complex was also found tomodulate Hpo
signaling by interacting with Yap/Taz in Eph4 mammary epithe-
lial cells (Varelas et al., 2010). Similar to regulation of Yap/Taz by
a-catenin and AMOT, the Crb complex sequesters and inacti-
vates Yap/Taz at high cell density in Eph4 cells. Disrupting the
complex by knocking down either Crb3 or Pals1 relocalizes
Yap/Taz to the nucleus and promotes its dephosphorylation
and activation. It seems likely that the function of AMOT and
the Crb complex in Yap/Tz regulation are interrelated, given
that AMOT has been shown to bind PatJ, which is also a compo-
nent of the mammalian Crb complex (Wells et al., 2006). Another
interesting finding from the Varelas et al. (2010) study is that loss
of Crb3 enhances TGF-b signaling and promotes EMT, sug-
gesting a link between Crb, Yap/Taz, and TGF-b in tumor
progression.
Loss of the basolateral polarity protein Lgl was also recently
shown to modulate Hpo signaling in the Drosophila eye, but,
unlike crbmutants, Ex protein was not mislocalized in lglmutant
tissue (Grzeschik et al., 2010). Instead, Hpo and its negative
regulator Ras-associated family protein (Rassf) are mislocalized,
suggesting that Lgl acts at the level of Hpo to regulate the
pathway. Mechanistically it is unclear how Lgl regulates the
Hpo pathway, but this effect might be mediated through aPKC
or other apical polarity proteins because depletion of aPKC sup-
pressed overgrowth in lgl mutants (Grzeschik et al., 2010). It is
worth noting that Lgl1 knockout mice exhibit brain dysplasia
and loss of cell polarity in neuroepithelial cells, suggesting that
the role of Lgl1 as a tumor suppressor has been evolutionarily
conserved (Klezovitch et al., 2004). Thus, it would be interesting
to determine whether Lgl1 or other mammalian orthologs of
Drosophila basolateral proteins similarly regulate Hpo signaling.
Studies in flies, zebrafish, and human cells have linked another
basolateral polarity protein, Scribble, to the Hpo pathway as
well (Skouloudaki et al., 2009; Cordenonsi et al., 2011; Chen
et al., 2012). Together, these studies suggest that loss of cell
polarity, which has long been recognized as a hallmark of human
cancer, has a causal relationship at least in part via its effects on
the Hpo pathway.
Concluding Remarks
Recent studies in Drosophila and mammals demonstrate the
importance of basic cellular processes such as actin polymeriza-
tion, cell polarity, and cell adhesion in Hpo pathway regulation.
Moreover, they reveal that Yki/Yap activity can be inhibited
through two distinct mechanisms: (1) the phosphorylation of
Yki/Yap by the canonical Hpo pathway, which in turn promotes
Yki/Yap degradation and cytoplasmic retention by 14-3-3, and
(2) the recruitment of Yki/Yap to the cell cortex by direct
protein-protein interactions. Although these mechanisms are
not mutually exclusive, it is becoming clear that in certain
contexts canonical Hpo signaling is not required to sequester
Yki/Yap in the cytoplasm and restrict its oncogenic activity. For
example, in the Drosophila wing, Ex, Hpo, and Wts regulate
Yki’s subcellular localization independently of its phosphoryla-
tion state, and in mouse keratinocytes, a-catenin recruits Yap
to AJs independently of MST and Lats kinase activity (Badouel
et al., 2009; Oh et al., 2009; Schlegelmilch et al., 2011; Silvis
et al., 2011). In addition, core pathway components such as
Mats/MOB1 become activated at the cell membrane whenDevelopmental Cell 22, April 17, 2012 ª2012 Elsevier Inc. 699
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highlighting the importance of the cell cortex as an organizing
center for Hpo pathway activity. In regard to this, it is interesting
to note that some Yki/Yap normally localizes to the cell cortex in
both Drosophila and mammalian cells (Zhang et al., 2009; Zhao
et al., 2011). An interesting future question will be to determine
whether Yki/Yap or other Hpo pathway components have func-
tions at the cell membrane that are independent of their roles in
transcription.
Given that the actin cytoskeleton and intercellular junctions
both regulate Hpo signaling, it seems likely that these twomodes
of regulation are interrelated. An intriguing possibility is that the
cortical cytoskeleton and junctional proteins cooperate to relay
information about cell density and mechanical tension to the
Hpo pathway. Indeed, this notion is supported by recent evi-
dence in mammalian cells showing that mechanical tension
can influence Yap activation (Dupont et al., 2011; Wada et al.,
2011; Zhao et al., 2012). The addition of actin-modulating and
junctional proteins to the Hpo signaling milieu makes the idea
of mechanosensory regulation of tissue growth even more
appealing. A challenge for future investigators will be to develop
a cohesive Hpo signaling model that takes into account all of the
known functional interactions between cell polarity, intercellular
junctions, and the actin cytoskeleton.
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